BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 17426210)

  • 1. Copeptin, C-reactive protein, and procalcitonin as prognostic biomarkers in acute exacerbation of COPD.
    Stolz D; Christ-Crain M; Morgenthaler NG; Leuppi J; Miedinger D; Bingisser R; Müller C; Struck J; Müller B; Tamm M
    Chest; 2007 Apr; 131(4):1058-67. PubMed ID: 17426210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of assessment tests in patients with acute exacerbation of chronic obstructive pulmonary disease.
    Zhao YF; Jiang YP; Zhou LF; Wu XL
    Am J Med Sci; 2014 May; 347(5):393-9. PubMed ID: 24270077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of diagnostic values of procalcitonin, C-reactive protein and blood neutrophil/lymphocyte ratio levels in predicting bacterial infection in hospitalized patients with acute exacerbations of COPD.
    Tanrıverdi H; Örnek T; Erboy F; Altınsoy B; Uygur F; Atalay F; Tor MM
    Wien Klin Wochenschr; 2015 Oct; 127(19-20):756-63. PubMed ID: 25586444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma concentrations of copeptin, C-reactive protein and procalcitonin are positively correlated with APACHE II scores in patients with sepsis.
    Jiang L; Feng B; Gao D; Zhang Y
    J Int Med Res; 2015 Apr; 43(2):188-95. PubMed ID: 25691533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and diagnostic significance of copeptin in acute exacerbation of chronic obstructive pulmonary disease and acute heart failure: data from the ACE 2 study.
    Winther JA; Brynildsen J; Høiseth AD; Strand H; Følling I; Christensen G; Nygård S; Røsjø H; Omland T
    Respir Res; 2017 Nov; 18(1):184. PubMed ID: 29100503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein and copeptin: prognostic predictors in chronic obstructive pulmonary disease exacerbations.
    Antonescu-Turcu AL; Tomic R
    Curr Opin Pulm Med; 2009 Mar; 15(2):120-5. PubMed ID: 19532026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Procalcitonin as a prognostic factor in severe acute exacerbation of chronic obstructive pulmonary disease.
    Rammaert B; Verdier N; Cavestri B; Nseir S
    Respirology; 2009 Sep; 14(7):969-74. PubMed ID: 19659517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
    Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-terminal provasopressin (copeptin) as a novel and prognostic marker in acute myocardial infarction: Leicester Acute Myocardial Infarction Peptide (LAMP) study.
    Khan SQ; Dhillon OS; O'Brien RJ; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
    Circulation; 2007 Apr; 115(16):2103-10. PubMed ID: 17420344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term Prognosis in COPD Exacerbation: Role of Biomarkers, Clinical Variables and Exacerbation Type.
    Grolimund E; Kutz A; Marlowe RJ; Vögeli A; Alan M; Christ-Crain M; Thomann R; Falconnier C; Hoess C; Henzen C; Zimmerli W; Mueller B; Schuetz P;
    COPD; 2015 Jun; 12(3):295-305. PubMed ID: 25230352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin vs C-reactive protein as predictive markers of response to antibiotic therapy in acute exacerbations of COPD.
    Daniels JM; Schoorl M; Snijders D; Knol DL; Lutter R; Jansen HM; Boersma WG
    Chest; 2010 Nov; 138(5):1108-15. PubMed ID: 20576731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD.
    Stolz D; Breidthardt T; Christ-Crain M; Bingisser R; Miedinger D; Leuppi J; Mueller B; Tamm M; Mueller C
    Chest; 2008 May; 133(5):1088-94. PubMed ID: 18339792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
    Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
    Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.
    Bafadhel M; Clark TW; Reid C; Medina MJ; Batham S; Barer MR; Nicholson KG; Brightling CE
    Chest; 2011 Jun; 139(6):1410-1418. PubMed ID: 21030489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the Serotonin Pathway is Associated with Poor Outcome in COPD Exacerbation: Results of a Long-Term Cohort Study.
    Meier MA; Ottiger M; Vögeli A; Steuer C; Bernasconi L; Thomann R; Christ-Crain M; Henzen C; Hoess C; Zimmerli W; Huber A; Mueller B; Schuetz P
    Lung; 2017 Jun; 195(3):303-311. PubMed ID: 28434116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
    Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
    Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnostic and Prognostic Value of Inflammatory Parameters Including Neopterin in the Setting of Pneumonia, COPD, and Acute Exacerbations.
    Pizzini A; Lunger F; Sahanic A; Nemati N; Fuchs D; Weiss G; Kurz K; Bellmann-Weiler R
    COPD; 2017 Jun; 14(3):298-303. PubMed ID: 28548632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of pro-adrenomedullin and copeptin in acute infective endocarditis.
    Zampino R; Iossa D; Ursi MP; Bertolino L; Andini R; Molaro R; Fabrazzo O; Leonardi S; Atripaldi L; Durante-Mangoni E
    BMC Infect Dis; 2021 Jan; 21(1):23. PubMed ID: 33413127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copeptin, procalcitonin and routine inflammatory markers-predictors of infection after stroke.
    Fluri F; Morgenthaler NG; Mueller B; Christ-Crain M; Katan M
    PLoS One; 2012; 7(10):e48309. PubMed ID: 23118979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discriminate use of antibiotics for exacerbation of COPD.
    Stolz D; Tamm M
    Curr Opin Pulm Med; 2009 Mar; 15(2):126-32. PubMed ID: 19532027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.